Advanced Enzyme (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Advanced Enzyme Technologies Limited |
|||
|
Price: ₹361.20 | ||
| 52 Week Low: ₹334.05 52 Week High: ₹571.00 |
|||
| Market Capital: 4,226.86 Crore (Smallcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Advanced Enzyme Share Price Target For 2024
- 1.1.1: Advanced Enzyme Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Advanced Enzyme Share Price Target For 2025
- 1.2.1: Advanced Enzyme Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Advanced Enzyme Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Advanced Enzyme Brief Company Overview
- 4: Advanced Enzyme Financial Performance
- 4.0.1: Is Advanced Enzyme A Good Buy For Long Term?
To predict the Advanced Enzyme's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Advanced Enzyme Share Price Target For 2024
The line chart displays the monthly closing prices of Advanced Enzyme with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Advanced Enzyme shares in 2024, see the table below.
Advanced Enzyme Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 377.4 (+4.48%) | Price Action: 16 Dec 2024 Low |
| 2024 Target 2 | 373.24 (+3.33%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 369.2 (+2.21%) | Price Action: 18 Dec 2024 Low |
| Current Price | 361.20 | Advanced Enzyme's share price as of 20 Dec 2024 |
| Stop Loss 1 | 355.4 (-1.61%) | Price Action: Jul 2024 Low |
| Stop Loss 2 | 347.63 (-3.76%) | Price Action: Dec 2016 Low |
| Stop Loss 3 | 342.8 (-5.10%) | Price Action: Feb 2022 High |
Short-Term Technical Outlook
Current Technical Position: Advanced Enzyme is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹378.09 serves as the nearest technical reference point.
Historical Returns: 3-month: -28.18% | 6-month: -5.10% | 1-year: -2.46%
Advanced Enzyme Share Price Target For 2025
The line chart displays the monthly closing prices of Advanced Enzyme with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Advanced Enzyme shares in 2025, see the table below.
Advanced Enzyme Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 538.93 (+49.20%) | Price Action: Chart |
| 2025 Target 2 | 528.88 (+46.42%) | Price Action: Chart |
| 2025 Target 1 | 523.64 (+44.97%) | Fibonacci Extension Level 64.90% |
| Current Price | 361.20 | Advanced Enzyme's share price as of 20 Dec 2024 |
| Stop Loss 1 | 321.9 (-10.89%) | Price Action: Oct 2016 Low |
| Stop Loss 2 | 317.4 (-12.13%) | Price Action: Apr 2022 High |
| Stop Loss 3 | 313.88 (-13.11%) | Price Action: Dec 2022 High |
Long-Term Technical Outlook
52-Week Range Analysis: Advanced Enzyme is currently trading near its 52-week low of ₹334.05, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -2.46% | 3-year: +14.67% | 5-year: +127.30%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Advanced Enzyme Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹361.20 | ||
| 2024 | ₹451.56 | +25.02% | ₹458.33 |
| 2025 | ₹540.70 | +19.74% | ₹548.81 |
| 2026 | ₹612.40 | +13.26% | ₹621.59 |
| 2027 | ₹718.53 | +17.33% | ₹729.31 |
| 2028 | ₹758.62 | +5.58% | ₹770.00 |
| 2029 | ₹829.81 | +9.38% | ₹842.26 |
| 2030 | ₹928.63 | +11.91% | ₹942.56 |
| 2031 | ₹996.62 | +7.32% | ₹1,011.57 |
| 2032 | ₹1,119.09 | +12.29% | ₹1,135.88 |
| 2033 | ₹1,139.10 | +1.79% | ₹1,156.19 |
| 2034 | ₹1,208.06 | +6.05% | ₹1,226.18 |
| 2035 | ₹1,316.55 | +8.98% | ₹1,336.30 |
| 2036 | ₹1,380.85 | +4.88% | ₹1,419.50 |
| 2037 | ₹1,519.64 | +10.05% | ₹1,542.43 |
| 2038 | ₹1,519.59 | 0.00% | ₹1,542.38 |
| 2039 | ₹1,538.64 | +1.25% | ₹1,619.78 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Advanced Enzyme Brief Company Overview
Advanced Enzyme Technologies Limited: A Global Enzyme and Probiotic Leader Established in 1957, Advanced Enzyme Technologies Limited (AET) is a globally renowned company headquartered in Thane, India. AET has a strong reputation for its extensive research and development...
capabilities, producing enzymes and probiotics for various industries. Key Products and Services: Enzymes for human healthcare, animal nutrition, and food processing Non-food processing enzymes for textiles, leather, paper, detergents, biofuels, and biocatalysis Probiotics Diverse Product Range: AET boasts a diverse product range, offering customized solutions tailored to various industrial needs, including pharmaceuticals, food, beverages, and textiles. Global Presence: AET has established a strong market presence across India, the United States, Asia, Europe, and other countries, delivering innovative and high-quality products to customers worldwide. Commitment: AET is committed to continuous research, innovation, and customer satisfaction, ensuring that its products meet the evolving demands of the market.Advanced Enzyme Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 4,226.86 Crore | Market valuation of Advanced Enzyme's shares. |
| Revenue (TTM) | 619.36 Crore | Total revenue generated by Advanced Enzyme over the past twelve months. |
| Net Income (TTM) | +1,370,720,000.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +22.94% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +22.13% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-7.40% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-4.60% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
3.37 | Company's total debt divided by total shareholder equity. |
| Total Debt | 46.91 Crore | Sum of Advanced Enzyme's current & long-term financial obligations. |
| Total Cash | 506.99 Crore | Total amount of liquid funds available to Advanced Enzyme. |
| Beta | 0.39 | Beta is less than 1 indicating that the Advanced Enzyme's price is less volatile than the market. |
Is Advanced Enzyme A Good Buy For Long Term?
Advanced Enzyme Technologies, a small-cap stock with a market capitalization of ₹4,226.86 crore, shows mixed signals. While its ₹137.07 crore net profit (22.13% margin) on ₹619.36 crore revenue in the last 12 months is positive, a -4.6% year-on-year earnings decline and -7.4% sequential revenue drop raise concerns. The company holds a healthy cash balance of ₹506.99 crore against a debt of ₹46.91 crore. Despite strong 5-year returns (107.27%), recent performance (-12.26% in the last 3 months) is weak. Therefore, based on current data, it's an average buy for long-term investors, warranting further investigation.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
